Subtype
Endometrial Neoplasm
CI-CAN-00007648Explore in graph →
Non-malignant400 active trials4 approved drugs28 evidence items
Loading cancer entity…
Subtype
CI-CAN-00007648Explore in graph →
Clinical trials
1,340 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03169023 | Scale Down for Endometrial Cancer | completed | N/A | 155 | Washington University School of MedicineOTHER | 1 | Feb 28, 2019 | clinicaltrials |
| NCT00331760 | Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery | completed | Phase 2 | 106 | Radiation Therapy Oncology GroupNETWORK | 2 | Feb 26, 2019 | clinicaltrials |
| NCT03112733 | Serum Biomarkers in Diagnosis and Predicting Prognosis of Ovarian Cancers | unknown | — | 171 | Ilker KahramanogluOTHER | 1 | Feb 26, 2019 | clinicaltrials |
| NCT03838055 | Sentinel Node Detection in Endometrial Cancer: A Consolidation Study on Detection Rates of Metastatic Disease | unknown | N/A | 362 | Region SkaneOTHER | 1 | Feb 12, 2019 | clinicaltrials |
| NCT02433626 | Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies(COTI2-101) | unknown | Phase 1 | 51 | Critical Outcome Technologies Inc.INDUSTRY | 1 | Feb 1, 2019 | clinicaltrials |
| NCT00910091 | The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer | completed | Phase 2 | 73 | IpsenINDUSTRY | 12 | Jan 30, 2019 | clinicaltrials |
| NCT01010126 | Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer | completed | Phase 2 | 252 | National Cancer Institute (NCI)NIH | 2 | Jan 25, 2019 | clinicaltrials |
| NCT03459976 | HE4 is a Beneficial Biomarker in Endometrial Cancer(HE4) | unknown | — | 87 | Ain Shams UniversityOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT03322176 | Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing | unknown | — | 200 | Data Collection Analysis Business ManagementOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT03804463 | The Multicentic Trial in Fertility-sparing Treatment and Ovarian Preservation Management for Early Endometrial Cancer | unknown | N/A | 170 | Min WangOTHER | 1 | Jan 15, 2019 | clinicaltrials |
| NCT01251354 | Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy | terminated | Phase 2 | 6 | IpsenINDUSTRY | 2 | Jan 14, 2019 | clinicaltrials |
| NCT00309959 | ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer | completed | Phase 2 | 37 | Gynecologic Oncology GroupNETWORK | 1 | Jan 8, 2019 | clinicaltrials |
| NCT01420081 | A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer | terminated | Phase 2 | 67 | PfizerINDUSTRY | 8 | Jan 8, 2019 | clinicaltrials |
| NCT03778255 | Sentinel Lymph Node Mapping In Endometrial Cancer(SLNMIEC) | unknown | N/A | 635 | Peking University People's HospitalOTHER | 1 | Dec 19, 2018 | clinicaltrials |
| NCT03553589 | Biomarkers for Diagnosis and Prognosis of Endometrial Carcinoma(BioEndoCar) | unknown | — | 400 | Andrea RomanoOTHER | 3 | Dec 5, 2018 | clinicaltrials |
| NCT03752606 | Application of Tachosil During Lymphadenectomy | completed | Phase 4 | 50 | Medical University of LublinOTHER | 1 | Nov 26, 2018 | clinicaltrials |
| NCT03744962 | MSI in Circulatory DNA of Endometrial Cancer | unknown | — | 100 | Lei LiOTHER | 1 | Nov 19, 2018 | clinicaltrials |
| NCT03653819 | High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower Limbs | completed | N/A | 20 | Herlev and Gentofte HospitalOTHER | 1 | Nov 15, 2018 | clinicaltrials |
| NCT03291106 | Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer | unknown | — | 1,500 | Lei LiOTHER | 1 | Nov 14, 2018 | clinicaltrials |
| NCT01262040 | Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive | completed | N/A | 154 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 7, 2018 | clinicaltrials |
| NCT02868892 | A Study of Pemetrexed in Recurrent Cervical Adenocarcinomas | terminated | Phase 2 | 6 | Western Regional Medical CenterOTHER | 1 | Nov 2, 2018 | clinicaltrials |
| NCT00064077 | Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix | completed | Phase 3 | 513 | Gynecologic Oncology GroupNETWORK | 1 | Oct 17, 2018 | clinicaltrials |
| NCT02589366 | Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium | terminated | Phase 1 | 2 | University of California, San DiegoOTHER | 1 | Oct 15, 2018 | clinicaltrials |
| NCT02667431 | Cancer of the Uterus and Treatment of Stress Urinary Incontinence(CUTI) | unknown | — | 556 | Women and Infants Hospital of Rhode IslandOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT00003821 | Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer | withdrawn | Phase 2 | 0 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Sep 18, 2018 | clinicaltrials |
| NCT02091050 | 2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy | completed | Phase 2 | 60 | AC Camargo Cancer CenterOTHER | 1 | Aug 31, 2018 | clinicaltrials |
| NCT03456791 | Human Epididymis Protein 4 in Endometrial Carcinoma | completed | — | 84 | Ain Shams UniversityOTHER | 1 | Aug 14, 2018 | clinicaltrials |
| NCT03469531 | Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer | unknown | Phase 2 | 100 | Zhujiang HospitalOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT00916708 | Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients(TOTEM) | unknown | N/A | 1,884 | Azienda Ospedaliera San Giovanni BattistaOTHER | 1 | Aug 2, 2018 | clinicaltrials |
| NCT01767155 | Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer(ZoptEC) | completed | Phase 3 | 511 | AEterna ZentarisINDUSTRY | 22 | Jul 31, 2018 | clinicaltrials |
| NCT00268918 | Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients | completed | Phase 1 | 24 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 27, 2018 | clinicaltrials |
| NCT01673022 | Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence Imaging(FIRES) | completed | N/A | 430 | Indiana UniversityOTHER | 1 | Jul 24, 2018 | clinicaltrials |
| NCT02774395 | Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine | completed | — | 40 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Jul 24, 2018 | clinicaltrials |
| NCT02826291 | SLNM in Endometrial Cancer Combined With OSNA(SLNM/OSNA) | completed | — | 58 | Charles University, Czech RepublicOTHER | 1 | Jul 18, 2018 | clinicaltrials |
| NCT03567655 | Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer | unknown | Phase 2 | 41 | Asan Medical CenterOTHER | 1 | Jun 26, 2018 | clinicaltrials |
| NCT01764802 | Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer | completed | Phase 2 | 100 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | May 30, 2018 | clinicaltrials |
| NCT03538704 | Effect of Fertility-sparing Therapy of Early Endometrial Cancer(ECFerSp) | unknown | N/A | 80 | Peking University People's HospitalOTHER | 1 | May 29, 2018 | clinicaltrials |
| NCT01440998 | Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Apr 5, 2018 | clinicaltrials |
| NCT00483327 | Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate | completed | Phase 2 | 31 | NYU Langone HealthOTHER | 1 | Apr 4, 2018 | clinicaltrials |
| NCT00909896 | Study of Post Operative Pain in Endometrial Cancer Robotic Versus Laparotomy | completed | — | 142 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 2, 2018 | clinicaltrials |
| NCT02765698 | Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer | terminated | — | 2 | Mayo ClinicOTHER | 1 | Mar 27, 2018 | clinicaltrials |
| NCT00369122 | Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 2 | Mar 20, 2018 | clinicaltrials |
| NCT01005329 | Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer | completed | Phase 2 | 34 | National Cancer Institute (NCI)NIH | 3 | Mar 15, 2018 | clinicaltrials |
| NCT01642082 | Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | 28 | Gynecologic Oncology GroupNETWORK | 1 | Mar 13, 2018 | clinicaltrials |
| NCT01847703 | Robotic Versus Abdominal Surgery for Endometrial Cancer(RASHEC) | completed | N/A | 120 | Karolinska InstitutetOTHER | 1 | Mar 6, 2018 | clinicaltrials |
| NCT03076372 | A Study Evaluating MM-310 in Patients With Solid Tumors | unknown | Phase 1 | 34 | Merrimack PharmaceuticalsINDUSTRY | 1 | Feb 27, 2018 | clinicaltrials |
| NCT01210222 | Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer | completed | Phase 2 | 35 | Gynecologic Oncology GroupNETWORK | 1 | Feb 23, 2018 | clinicaltrials |
| NCT03291275 | Survival Outcomes of Uterine Malignancies in Chinese Population | unknown | — | 10,000 | Lei LiOTHER | 1 | Feb 8, 2018 | clinicaltrials |
| NCT02178462 | Biomarkers for Gynecologic Cancer | unknown | — | 153 | Ajinomoto Co., Inc.INDUSTRY | 1 | Jan 31, 2018 | clinicaltrials |
| NCT02564276 | Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer | completed | Phase 3 | 132 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Jan 25, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Feb 28, 2019source: clinicaltrials